Terms: = Lymphoma AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Treatment
198 results:
1. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
[TBL] [Abstract] [Full Text] [Related]
2. The burden of acute lymphoid leukemia among adolescents and young adults in the Western Pacific Region: evidence from Global Burden Disease 2019.
Yang F; Zhang B; Lodder P; Guo J
Cancer Causes Control; 2024 May; 35(5):839-848. PubMed ID: 38227176
[TBL] [Abstract] [Full Text] [Related]
3. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract] [Full Text] [Related]
4. Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients.
Vanni A; Salvati L; Mazzoni A; Lamacchia G; Capone M; Francalanci S; Kiros ST; Cosmi L; Puccini B; Ciceri M; Sordi B; Rossolini GM; Annunziato F; Maggi L; Liotta F
Front Immunol; 2023; 14():1322594. PubMed ID: 38106404
[TBL] [Abstract] [Full Text] [Related]
5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
6. Risk of second primary cancers after a diagnosis of first primary cancer: A pan-cancer analysis and Mendelian randomization study.
Ruan X; Huang D; Zhan Y; Huang J; Huang J; Ng AT; Tsu JH; Na R
Elife; 2023 Nov; 12():. PubMed ID: 37917154
[TBL] [Abstract] [Full Text] [Related]
7. PD-1 blockade in combination with dasatinib potentiates induction of anti-acute lymphocytic leukemia immunity.
Koller P; Baran N; Harutyunyan K; Cavazos A; Mallampati S; Chin RL; Jiang Z; Sun X; Lee HH; Hsu JL; Williams P; Huang X; Curran MA; Hung MC; Konopleva M
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37793852
[TBL] [Abstract] [Full Text] [Related]
8. Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining.
Zaninelli S; Meli C; Borleri G; Quaroni M; Pavoni C; Gaipa G; Biondi A; Introna M; Golay J; Rambaldi A; Rambaldi B
Cytometry A; 2024 Feb; 105(2):112-123. PubMed ID: 37707318
[TBL] [Abstract] [Full Text] [Related]
9. Hand grip strength, short physical performance battery, and gait speed: key tools for function in Non-Hodgkin lymphoma.
García-Baztán A; Viguria-Alegria MC; Ramón-Espinoza MF; Tamayo-Rodríguez I; Gonzales-Montejo NJ; Martínez-Velilla N; Oteiza-Olaso J
Ann Hematol; 2023 Oct; 102(10):2823-2834. PubMed ID: 37566279
[TBL] [Abstract] [Full Text] [Related]
10. Structural basis of the interaction between BCL9-Pygo and LDB-SSBP complexes in assembling the Wnt enhanceosome.
Wang H; Bienz M; Yan XX; Xu W
Nat Commun; 2023 Jun; 14(1):3702. PubMed ID: 37349336
[TBL] [Abstract] [Full Text] [Related]
11. Unfavorable early-stage Hodgkin lymphoma: assessment of patient characteristics in a real-world setting.
Gautam S; Yeola S; Nahar A; Sarpong EM; Prescott J; Yang X; Sineshaw HM
Future Oncol; 2023 Jun; 19(18):1249-1259. PubMed ID: 37293737
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors and prognosis of early death in secondary hemophagocytic lymphohistiocytosis.
Zhang Q; Zhu L; Zhou D; Li L; Xie W; Tan Y; Ye X
Ann Hematol; 2023 Sep; 102(9):2301-2308. PubMed ID: 37266671
[TBL] [Abstract] [Full Text] [Related]
13. Trends in the Incidence of Kaposi's Sarcoma and Non-Hodgkin lymphoma in Northern Thailand during the Time Period of Universal Access to Antiretroviral treatment, 1998-2017.
Sripan P; Rerkasem A; Pongnikorn D; Chitapanarux I; Tangmunkongvorakul A; Ukranun W; Daoprasert K; Waisri N; Maneesai P; Srithanaviboonchai K; Aurpibul L
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1055-1061. PubMed ID: 36974561
[TBL] [Abstract] [Full Text] [Related]
14. Polo-like kinase 1 Decrease During Induction Therapy Could Indicate Good treatment Response, Favorable Risk Stratification, and Prolonged Survival in Pediatric Acute Lymphoblastic Leukemia.
Zhao Y; Li C; Cai C; Fu H; Zhao Z; Han J; Zhang F; Wang J
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e739-e745. PubMed ID: 36897339
[TBL] [Abstract] [Full Text] [Related]
15. General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia.
Gökbuget N; Ihrig K; Stadler M; Stelljes M; Elmaagacli A; Starck M; Raffel S; Stoltefuss A; Viardot A; Kreuzer KA; Heidenreich D; Renzelmann A; Wäsch R; Topp MS; Ritter B; Reimer P; Beck J; Westermann J; Wendelin K; Alakel N; Hanoun M; Serve H; Hoelzer D
Haematologica; 2023 Jul; 108(7):1758-1767. PubMed ID: 36779593
[TBL] [Abstract] [Full Text] [Related]
16. Dynamics of Age- versus Therapy-Related Clonal Hematopoiesis in Long-term Survivors of Pediatric Cancer.
Hagiwara K; Natarajan S; Wang Z; Zubair H; Mulder HL; Dong L; Plyler EM; Thimmaiah P; Ma X; Ness KK; Li Z; Mulrooney DA; Wilson CL; Yasui Y; Hudson MM; Easton J; Robison LL; Zhang J
Cancer Discov; 2023 Apr; 13(4):844-857. PubMed ID: 36751942
[TBL] [Abstract] [Full Text] [Related]
17. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
[TBL] [Abstract] [Full Text] [Related]
18. Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.
Boissel N; Chiaretti S; Papayannidis C; Ribera JM; Bassan R; Sokolov AN; Alam N; Brescianini A; Pezzani I; Kreuzbauer G; Zugmaier G; Foà R; Rambaldi A
Blood Cancer J; 2023 Jan; 13(1):2. PubMed ID: 36599847
[TBL] [Abstract] [Full Text] [Related]
19. Advances in the treatment of postoperative recurrence of non-small cell lung cancer and their impact on survival in Asian patients.
Hashimoto K; Ariyasu R; Ichinose J; Matsuura Y; Nakao M; Amino Y; Uchibori K; Kitazono S; Yanagitani N; Okumura S; Nishio M; Mun M
J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1565-1574.e1. PubMed ID: 36137840
[TBL] [Abstract] [Full Text] [Related]
20. Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer.
Aggarwal R; Starodub AN; Koh BD; Xing G; Armstrong AJ; Carducci MA
Clin Cancer Res; 2022 Sep; 28(18):3979-3989. PubMed ID: 35816286
[TBL] [Abstract] [Full Text] [Related]
[Next]
